Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1105

    1.

    Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

    Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.

    Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.PMID: 18025440 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

    Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.PMID: 17049139 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

    Clark W, Jobanputra P, Barton P, Burls A.

    Health Technol Assess. 2004 May;8(18):iii-iv, ix-x, 1-105. Review.PMID: 15130461 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.

    Choy EH, Smith C, Doré CJ, Scott DL.

    Rheumatology (Oxford). 2005 Nov;44(11):1414-21. Epub 2005 Jul 19. Review.PMID: 16030080 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.

    Doan QV, Chiou CF, Dubois RW.

    J Manag Care Pharm. 2006 Sep;12(7):555-69. Review.PMID: 16981801 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

    Culy CR, Keating GM.

    Drugs. 2002;62(17):2493-537. Review.PMID: 12421111 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis.

    Katchamart W, Trudeau J, Phumethum V, Bombardier C.

    Ann Rheum Dis. 2009 Jul;68(7):1105-12. Epub 2008 Dec 3. Review.PMID: 19054823 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs.

    Dale J, Alcorn N, Capell H, Madhok R.

    Nat Clin Pract Rheumatol. 2007 Aug;3(8):450-8; quiz, following 478. Review.PMID: 17664952 [PubMed - indexed for MEDLINE]Related articles

    9.

    Adalimumab: a review of its use in rheumatoid arthritis.

    Bang LM, Keating GM.

    BioDrugs. 2004;18(2):121-39. Review.PMID: 15046527 [PubMed - indexed for MEDLINE]Related articles

    10.

    Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

    Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.

    Drug Saf. 2002;25(3):173-97. Review.PMID: 11945114 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

    Gartlehner G, Gaynes BN, Hansen RA, Thieda P, DeVeaugh-Geiss A, Krebs EE, Moore CG, Morgan L, Lohr KN.

    Ann Intern Med. 2008 Nov 18;149(10):734-50. Review.PMID: 19017592 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.

    Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA; RADIUS Investigators.

    Curr Med Res Opin. 2006 Jan;22(1):185-98.PMID: 16393444 [PubMed - indexed for MEDLINE]Related articles

    13.

    Spotlight on etanercept in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

    Culy CR, Keating GM.

    BioDrugs. 2003;17(2):139-45. Review.PMID: 12641492 [PubMed - indexed for MEDLINE]Related articles

    14.

    Remission in rheumatoid arthritis: wishful thinking or clinical reality?

    Sesin CA, Bingham CO 3rd.

    Semin Arthritis Rheum. 2005 Dec;35(3):185-96.PMID: 16325659 [PubMed - indexed for MEDLINE]Related articles

    15.

    Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

    Lyseng-Williamson KA, Foster RH.

    Pharmacoeconomics. 2004;22(2):107-32. Review.PMID: 14731052 [PubMed - indexed for MEDLINE]Related articles

    16.

    Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.

    Gibofsky A, Palmer WR, Goldman JA, Lautzenheiser RL, Markenson JA, Weaver A, Schiff MH, Keystone EC, Paulus HE, Harrison MJ, Whitmore JB, Leff JA.

    Curr Med Res Opin. 2006 Jan;22(1):169-83.PMID: 16393443 [PubMed - indexed for MEDLINE]Related articles

    17.

    Anakinra for rheumatoid arthritis.

    Mertens M, Singh JA.

    Cochrane Database Syst Rev. 2009 Jan 21;(1):CD005121. Review.PMID: 19160248 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial.

    Burmester GR, Mariette X, Montecucco C, Monteagudo-Sáez I, Malaise M, Tzioufas AG, Bijlsma JW, Unnebrink K, Kary S, Kupper H.

    Ann Rheum Dis. 2007 Jun;66(6):732-9. Epub 2007 Feb 28.PMID: 17329305 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

    Kremer JM.

    Ann Intern Med. 2001 Apr 17;134(8):695-706. Review.PMID: 11304108 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study.

    Capell HA, Madhok R, Porter DR, Munro RA, McInnes IB, Hunter JA, Steven M, Zoma A, Morrison E, Sambrook M, Wui Poon F, Hampson R, McDonald F, Tierney A, Henderson N, Ford I.

    Ann Rheum Dis. 2007 Feb;66(2):235-41. Epub 2006 Aug 22.PMID: 16926184 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data